Nine years after its establishment, recently, Jiangxi Yimai Sunshine Group Co., Ltd. *** hereinafter referred to as "Yimai Sunshine") finally submitted a prospectus to the Hong Kong Stock Exchange, submitting to the Hong Kong Stock Exchange twice a yearWhere does the confidence come from?
In terms of policy, in October 2013, the first "Several Opinions on Promoting the Development of Health Service Industry" was promulgated, vigorously developing third-party services, guiding the development of professional medical imaging centers and testing centers, which were includedIn August 2016, the National Health and Family Planning Commission issued the Notice of the National Health and Family Planning Commission on the Basic Standards and Management Specifications of Medical Imaging Diagnostic Centers, which clarified the status of third-party medical imaging diagnostic centers as independent legal persons for the first time and further clarified the license approval standardsIn 2022, in the "14th Five-Year Plan" issued by the General Office of the People's Republic of China, it is once again proposed to "guide and promote the standardized development of independent institutions such as medical testing centers and medical imaging centers", and independent third-party medical institutions will enter the ...... of standardized developmentFollowing the policy direction, Yimai Sunshine grasped the contradiction between supply and demand in the medical service market, formulated the establishment of a hierarchical diagnosis and treatment system and the organizational form of the medical alliance, and ran out a set of formed service models.
After successfully opening the market, among the 10 types of independent third-party medical institutions, the development of medical imaging services in the field is the most difficult, so in order to achieve better development, Yimai Sunshine has further consolidated the foundation of brand development through the continuous improvement of talents and equipment. Through continuous R&D and innovation, the company continues to improve its leading position in participating in the formulation of image service standards, technology and data service capabilities, etc., and has completed the internal data standardization work and is being invited to participate in the formulation of industry standards.
However, no matter from the perspective of policy guidance or market demand, Yimai Sunshine has the confidence to become the "first stock of medical imaging". As the first medical imaging medical group in China to officially impact the IPO, if Yimai Sunshine can be successfully listed on the Hong Kong Stock Exchange, then Yimai Sunshine will also usher in higher quality development.